SunTrust Robinson Humphrey Raises Price Target On Amedisys (AMED) To $78
Tweet Send to a Friend
Today, SunTrust Robinson Humphrey raises price target on Amedisys (Nasdaq: AMED) from $70 to $78. SunTrust Robinson Humphrey has a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
